NanoViricides

Shelton biotech NanoViricides raises $2M in stock offering

NanoViricides returns to investors as it pushes experimental antiviral treatments forward.

Shelton biotech raises $6M in direct offering, but warns of limited cash runway

Despite a recent capital raise, Shelton-based antiviral drug developer NanoViricides Inc. disclosed it does not have enough...

Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.

Latest Stories

West Hartford council OKs $20M settlement in lawsuit over...

Connecticut wins major federal grant for quantum computing effort

Moody’s shifts Eversource outlook to stable after Aquarion sale

🔒State Comptroller orders monthly reports on P-Card use

More Business News

Movers & Shakers

Dimeo Construction Co. Welcomes Blakely S. Dimeo as Business Development Manager

Jon Scavone Joins Titan Energy as their Director, Sustainability Services

Marysa Santos Joins CBIZ as Managing Director in Hartford

Community Housing Advocates CEO Receives Homelessness Social Justice Award

More Movers & Shakers | Submit an Announcement

Thought Leadership

Built in Connecticut, Making an Impact Worldwide: Why Local...

Navigating the New Economics of Healthcare: Five Financial Moves...

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job

Upcoming Events

More Events | Submit an Event